Which path to follow? Utilizing proteomics to improve therapy choices for breast cancer patients.

Blucher, Aurora S; Mills, Gordon B; Tsang, Yiu Huen

Blucher, Aurora S; Mills, Gordon B; Tsang, Yiu Huen.

Affiliation

Blucher AS; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, OR, USA.
Mills GB; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, OR, USA.
Tsang YH; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, OR, USA.

Expert Rev Proteomics ; 17(3): 187-190, 2020 03.

Article in En | MEDLINE | ID: mdl-32306787

Subject(s)

Biomarkers, Tumor/genetics; Breast Neoplasms/genetics; Protein Array Analysis/trends; Proteomics/trends; Breast Neoplasms/pathology; Female; Humans

Key words

Breast cancer; RPPA; Reverse Phase Protein Arrays; mass spectrometry; precision medicine; proteomics; subtype; targeted therapies

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Biomarkers, Tumor / Protein Array Analysis / Proteomics Limits: Female / Humans Language: En Journal: Expert Rev Proteomics Journal subject: BIOQUIMICA Year: 2020 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google